Clinical Trial Update: Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety and immune response of a Modified Vaccinia Ankara (MVA) HIV vaccine in HIV-uninfected adults; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MVA HIV vaccine (Modified Vaccinia Ankara-based HIV vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: HIV Infections | Phase 1 | Status: COMPLETED